Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling

Ya Zhou; Li Mu; Xiao-Lu Liu; Qin Li; Li-Xuan Ding; Hong-Chuan Chen; Ying Hu; Fu-Shu Li; Wen-Juan Sun; Bai-Cheng He; Ke Wu

doi:10.1016/j.gendis.2019.10.017

您当前的位置：

首页 >

文章列表页 >

Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling

Full-length article | 更新时间：2022-06-24

- Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling
- Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling
- Genes & Diseases 2021年8卷第3期
- 作者机构：
  
  1. Department of Pharmacology, School of Pharmacy, Chongqing Medical University,Chongqing,PR China,400016
  2. Key Laboratory of Biochemistry and Molecular Pharmacology of Chongqing, Chongqing Medical University,Chongqing,PR China,400016
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2019.10.017
  中图分类号：
- 纸质出版日期：2021，
  
  网络出版日期：2021-5-1，
扫描看全文
Ya Zhou, Li Mu, Xiao-Lu Liu, 等. Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling[J]. Genes & Diseases, 2021,8(3).

Ya Zhou, Li Mu, Xiao-Lu Liu, et al. Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling[J]. Genes & Diseases, 2021,8(3).
Ya Zhou, Li Mu, Xiao-Lu Liu, 等. Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling[J]. Genes & Diseases, 2021,8(3). DOI： 10.1016/j.gendis.2019.10.017.

Ya Zhou, Li Mu, Xiao-Lu Liu, et al. Tetrandrine inhibits proliferation of colon cancer cells by BMP9/ PTEN/ PI3K/AKT signaling[J]. Genes & Diseases, 2021,8(3). DOI： 10.1016/j.gendis.2019.10.017.

摘要

Abstract

Despite advances in screening and treatment

colon cancer remains one of the leading causes of cancer-related death. Finding novel and useful drug treatment targets is also an urgent need for clinical applications. Tetrandrine (Tet) is extracted from the Chinese medicinal herbal medicine

which is a well-known calcium blocker with a variety of pharmacological activities

including anti-cancer. In this study

we recruited cell viability assay

flow cytometry analysis

cloning formation to confirm that Tet can inhibit the proliferation of SW620 cells

and induce apoptosis. Mechanically

we confirmed that Tet up-regulates the mRNA and protein level of BMP9 in SW620 cells. Over-expression BMP9 enhances the anti-cancer effects of Tet in SW620 cells

but these effects can be partly reversed by silencing BMP9. Also

Tet reduces phosphorylation of Aktl/2/3 in SW620 cells

which could be elevated by overexpressed BMP9 and impaired by silencing BMP9. Furthermore

we demonstrated that Tet reduces phosphorylated PTEN

which can be promoted by overexpressed BMP9

analogously also be attenuated through silencing BMP9. Finally

we introduced a xenograft tumor model to investigate the anti-proliferative effect of Tet

further to explore the effects of BMP9 and PTEN in SW620 cells. Our findings suggested that the anti-cancer activity of Tet in SW620 cells may be mediated partly by up-regulating BMP9

followed by inactivation PI3K/Akt through up-regulating PTEN at least.

关键词

Keywords

Akt1/2/3BMP9Colon cancerPTENTetrandrine (Tet)

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

Synthetic lethal approaches to target cancers with loss of PTEN function

BMP9 induces osteogenic differentiation through up-regulating LGR4 via the mTORC1/Stat3 pathway in mesenchymal stem cells

Mapk7 deletion in chondrocytes causes vertebral defects by reducing MEF2C/PTEN/AKT signaling

LncRNA H19 mediates BMP9-induced angiogenesis in mesenchymal stem cells by promoting the p53-Notch1 angiogenic signaling axis

PD-L1 expression is regulated by ATP-binding of the ERBB3 pseudokinase domain